Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Consort Medical plc

5 Dec 2019 15:25

 

FORM 8.3
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY 
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)
 
 

1

KEY INFORMATION
 
(a) Full name of discloser:MELQART ASSET MANAGEMENT (UK) LTD
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

N/A

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:Consort Medical plc
Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:04 December 2019
For an opening position disclosure, state the latest practicable date prior to the disclosure
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?NO
If it is a cash offer or possible cash offer, state “N/A”If YES, specify which:
 

2

POSITIONS OF THE PERSON MAKING THE DISCLOSURE
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
(a)Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
 
Class of relevant security:10p ordinary
 
 InterestsShort positions
 
Number%Number%
(1) Relevant securities owned and/or controlled:    
(2) Cash-settled derivatives:

1,010,000

2.05%

  
 
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:

1,010,000

2.05%

  
 
 
All interests and all short positions should be disclosed.
 
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 
(b)Rights to subscribe for new securities (including directors’ and other employee options)
 
Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 
 
 

3

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)Purchases and sales
 

Class of relevant security

Purchase/sale

Number of securities

Price per unit (GBp)

 
    
 
 
(b)Cash-settled derivative transactions
 

Class of relevant security

Product description

Nature of dealing

Number of reference securities

Price per unit (GBp)

e.g. CFD

e.g. opening/closing a long/short position, increasing/reducing a long/short position

10p ordinary

CFD

Increasing a long position

35,611

1042.59

 

 

10p ordinary

CFD

Increasing a long position

25,000

1040.00

 
 
(c)Stock-settled derivative transactions (including options)
 
(i)Writing, selling, purchasing or varying
 
Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypeExpiry dateOption money paid/ received per unit
e.g. American, European etc.
        
 
(ii)Exercise
 
Class of relevant securityProduct descriptionExercising/ exercised againstNumber of securitiesExercise price per unit
e.g. call option
     
 
 
(d)Other dealings (including subscribing for new securities)
 
Class of relevant securityNature of dealingDetailsPrice per unit (if applicable)
e.g. subscription, conversion
    
 
 
 

4

OTHER INFORMATION
 
(a)Indemnity and other dealing arrangements
 
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None
 
 
 
(b)Agreements, arrangements or understandings relating to options or derivatives
 
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or 
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”
None
 
 
 
(c)Attachments
 
Is a Supplemental Form 8 (Open Positions) attached?NO
 
 
Date of disclosure:

05 December 2019

Contact name:

J. H. Austin

Telephone number:

020 3826 4492

 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
 
The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20191205005056/en/

Copyright Business Wire 2019

Date   Source Headline
23rd Sep 20089:29 amRNSBlocklisting Interim Review
19th Sep 20087:00 amRNSInterim Management Statement
18th Sep 20084:41 pmRNSSecond Price Monitoring Extn
18th Sep 20084:35 pmRNSPrice Monitoring Extension
5th Sep 20081:43 pmRNSDirector/PDMR Shareholding
28th Aug 20082:32 pmRNSNotice of AGM
13th Aug 200812:03 pmRNSHolding(s) in Company
5th Aug 20085:26 pmRNSDirector/PDMR Shareholding
31st Jul 200811:55 amRNSTotal Voting Rights
21st Jul 20083:41 pmRNSHolding(s) in Company - Amend
15th Jul 20083:20 pmRNSHolding(s) in Company
15th Jul 200811:55 amRNSHolding(s) in Company
8th Jul 20085:24 pmRNSTransaction in Own Shares
25th Jun 20082:00 pmRNSHolding(s) in Company
25th Jun 20081:57 pmRNSHolding(s) in Company
24th Jun 20087:02 amRNSDirectorate Change
24th Jun 20087:00 amRNSFinal Results
20th Jun 20083:16 pmRNSNotification of major shareho
17th Jun 200810:43 amRNSAdditional Listing - Blocklis
13th Jun 20082:56 pmRNSHolding(s) in Company
28th May 200810:10 amRNSHolding(s) in Company
12th May 20084:02 pmRNSConsort Medical PLC
6th May 20085:33 pmRNSBlocklisting
1st May 20087:00 amRNSTrading Statement
28th Apr 200812:38 pmRNSBlocklisting
10th Apr 200810:23 amRNSHolding(s) in Company
4th Apr 20086:05 pmRNSHolding(s) in Company
1st Apr 200812:48 pmRNSBlocklisting
26th Mar 20089:59 amRNSHolding(s) in Company
20th Mar 200810:41 amRNSBlocklisting
14th Mar 20084:32 pmRNSHolding(s) in Company
11th Mar 20083:38 pmRNSResult of EGM
4th Mar 200810:08 amRNSHolding(s) in Company
26th Feb 20087:00 amRNSInterim Management Statement
15th Feb 20087:01 amRNSTermination of Agreement
22nd Jan 200810:05 amRNSBlocklisting
10th Jan 20084:57 pmRNSHolding(s) in Company
10th Jan 20084:56 pmRNSHolding(s) in Company
10th Jan 20083:14 pmRNSHolding(s) in Company
3rd Jan 20084:02 pmRNSHolding(s) in Company
20th Dec 200711:36 amRNSHolding(s) in Company
19th Dec 200710:43 amRNSHolding(s) in Company
17th Dec 20074:39 pmRNSDirector/PDMR Shareholding
17th Dec 20072:19 pmRNSDirector/PDMR Shareholding
13th Dec 200711:02 amRNSDirector/PDMR Shareholding
7th Dec 200712:25 pmRNSHolding(s) in Company
5th Dec 20078:10 amRNSHolding(s) in Company
5th Dec 20078:00 amRNSDirectorate Change
23rd Nov 20072:14 pmBUSRule 8.3 - Consort Medical Plc
23rd Nov 20072:04 pmRNSRule 8.3- Consort Medical PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.